BCC Secures DTC Eligibility

TORONTO, May 30, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTCQB:CBICF) today announced that the company has secured DTC Eligibility by The Depository Trust Company for its shares on the OTCQB marketplace, effective May 30, 2017....
Read More

BCC Commences Trading on OTCQB

TORONTO, May 22, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTCQB:CBICF) announced that BCC common shares will commence trading in the United States on the OTCQB Marketplace under the symbol “CBICF”, effective today, May 22...
Read More

BCC expands into second adult use market

TORONTO, May 04, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC)(OTC:CBICF) today announced that the Company, through its wholly owned U.S. subsidiary CGX, is exercising its option, and is acquiring a 100% interest in GreenMart of Nevad...
Read More